Medroxyprogesterone Acetate
NDC 67457-887, Medroxyprogesterone Acetate, injection, suspension, from Mylan Institutional LLC.
- Product NDC
- 67457-887
- Status
- Listed
- Labeler
- Mylan Institutional LLC
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210227
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67457-887 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEDROXYPROGESTERONE ACETATE150 mg/mL
Pharmacologic classes
Progesterone Congeners [CS]; Progestin [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67457-887-01 | 67457088701 | 25 VIAL in 1 CARTON (67457-887-01) / 1 mL in 1 VIAL (67457-887-00) |
| 67457-887-99 | 67457088799 | 1 VIAL in 1 CARTON (67457-887-99) / 1 mL in 1 VIAL (67457-887-00) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/60aba812-59eb-4d40-9b6b-d135dca9d36b
Use it
Look up 67457-887 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67457-887 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67457-887. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.